Transoral incisionless fundoplication (TIF) was shown to be more effective than taking the maximal proton pump inhibitor (PPI) dose in relieving heartburn, regurgitation, and other troublesome symptoms in patients with refractory gastroesophageal reflux disease (GERD).
Esophageal pH monitoring is more cost effective than the long-term use of proton-pump inhibitors (PPIs), since it can help rule out gastroesophageal reflux diseases (GERD) and avoid the unneeded costs associated with prolonged medication therapy.
Andrew J. Muir, MD, MHS, said having more antiviral hepatitis C drugs in the pipeline could spur more people to accept treatment and improve patient outcomes.
Citing an increased risk of liver injury observed in recent clinical trials, the US Food and Drug Administration (FDA) has limited Samsca (tolvaptan) treatment to 30 days and recommended the oral selective vasopressin V2-receptor antagonist be discontinued in patients with signs of liver disease or symptoms of liver injury.
Researchers claim that restricting dietary intake of fermentable short-chain carbohydrates improves GI symptoms in patients with IBS.
After noticing the ample adverse effects of second-line Helicobacter pylori eradication treatments that utilize tetracycline, furazolidone and proton-pump inhibitors, one group of gastroenterologists set to work adding a probiotic compound to the regimen in an attempt to increase the stomach bacteria's eradication rate while curbing those unwanted effects.
The stigma attached to chronic diseases such as IBS has been shown to negatively affect patients' self-image and sense of worth, leading to worse outcomes. Being aware of this and working to counteract the psychological effects of stigma can improve the patient-physician relationship and lead to better outcomes.
Data show that prevalence of concurrent IBS is actually higher in younger patients with OAB.
Researchers investigating the development of peptic ulcers in patients with liver cirrhosis reported that H. pylori is not the predominant etiology in this population.
Researchers in Taiwan report that type 2 diabetes is independently associated with increased risk of peptic ulcer bleeding.
Several studies recently have looked at the relationship between irritable bowel syndrome and increased pain sensitivity.
Study shows subtype of human stem cells can survive in the intestine and help replenish inflamed or damaged tissue.
A retrospective review of records from a large medical database finds that patients with sleep apnea face a substantially higher risk of developing peptic ulcer.
Study results show patients with IBS who drink four or more alcoholic drinks in one day may be more likely to experience diarrhea, nausea, stomach pain, and indigestion the next day.
Linzess (linaclotide capsules) was approved in August 2012 by the FDA as a once-daily treatment for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).
Women who suffer from celiac disease are more likely to report symptoms of depression and disordered eating, even if they follow a gluten-free diet, researchers have found.
Women with endometriosis are much more likely to develop inflammatory bowel disease than women without the reproductive disorder.
Radiofrequency treatment of patients with refractory gastroesophageal reflux disease appears to improve symptoms by decreasing compliance of the gastroesophageal junction, a new study suggests.
The death toll of the widely publicized listeria outbreak across the United States has risen from 13 to 18.
The FDA has approved Soliris (eculizumab) to treat pediatric and adult patients with atypical hemolytic uremic syndrome.
Two drugs which treat type 2 diabetes could lead to a substantially increased risk of pancreatitis and pancreatic cancer.
The primary endpoints have been met in a clinical trial of a drug for patients suffering from ulcerative colitis.
A researcher has proven that magnetic fields have the potential to act as a blood thinner, and possibly reduce the risk of heart attack.
Irregular periods in teenage girls may be linked to obesity, diabetes, reproductive issues, and heart disease.
The key to managing opioid-induced constipation is early recognition of the problem.
